HDL and sphingosine‐1‐phosphate activate stat3 in prostate cancer DU145 cells via ERK1/2 and S1P receptors, and promote cell migration and invasion

Abstract

These results suggest that the change in HDL plasma levels by androgen deprivation therapy may alter prostate cancer growth and metastasis.